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Intense effort has been devoted to understanding
predisposition to chronic systemic inflammation
because it contributes to cardiometabolic disease.
We demonstrate that deletion of the macrophage
vitamin D receptor (VDR) in mice (KODMAC) is suffi-
cient to induce insulin resistance by promoting M2
macrophage accumulation in the liver as well as
increasing cytokine secretion and hepatic glucose
production. Moreover, VDR deletion increases
atherosclerosis by enabling lipid-laden M2 mono-
cytes to adhere, migrate, and carry cholesterol
into the atherosclerotic plaque and by increasing
macrophage cholesterol uptake and esterification.
Increased foam cell formation results from lack of
VDR-SERCA2b interaction, causing SERCA dysfunc-
tion, activation of ER stress-CaMKII-JNKp-PPARg
signaling, and induction of the scavenger receptors
CD36 and SR-A1. Bone marrow transplant of VDR-
expressing cells into KODMAC mice improved
insulin sensitivity, suppressed atherosclerosis, and
decreased foam cell formation. The immunomodula-
tory effects of vitamin D in macrophages are thus
critical in diet-induced insulin resistance and athero-
sclerosis in mice.INTRODUCTION
The combination of type 2 diabetes (T2DM) and cardiovascular
disease (CVD) is the most common cause of morbidity and
mortality in Western populations. Despite the known link be-
tween chronic inflammation, insulin resistance, and accelerated
vascular disease, little is known about the mechanisms causing
this immune activation. Environmental conditions that regulate
macrophage differentiation and infiltration within metabolically1872 Cell Reports 10, 1872–1886, March 24, 2015 ª2015 The Authoractive tissues play a role in disease progression (Olefsky and
Glass, 2010). In high-fat-feeding-induced obese mice, classical
M1 macrophage infiltration into adipose and liver generates
pro-inflammatory cytokines and reactive oxygen intermediates
that accelerate additional immune cell recruitment and promote
insulin resistance (Lumeng et al., 2008). In early atherosclerotic
plaque formation, retention of cholesterol in the subendothelial
space triggers monocyte recruitment (Hansson and Hermans-
son, 2011). Both M1 and M2 macrophage phenotypes inter-
change dynamically depending on the plaque environment
(Bouhlel et al., 2007). M1 macrophages, stimulated by the
T-helper 1 cytokine, interferon g, or by cholesterol crystals, are
present early in the atherosclerotic plaque, promoting more
inflammation, but they have lower scavenger receptor expres-
sion and cholesterol deposition and migrate more easily out of
the plaque (Mantovani et al., 2009; Murray et al., 2014). In
contrast, T-helper 2 cytokines or activation of lipid-sensing nu-
clear receptors by polyunsaturated fatty acids promotes M2
macrophage differentiation. This heterogeneous M2 macro-
phage subtype displays a spectrum of inflammatory responses
(both pro- and anti-inflammatory) but is consistently character-
ized by expression of interleukin-10 (IL-10), arginase 1, and
mannose receptor (MR) that contribute to tissue repair. Interest-
ingly, these cells have increased scavenger receptor expression
facilitating foam cell formation, suggesting that modified lipid
deposition and M2 macrophage differentiation perpetuate one
another within the atherosclerosis plaque (Chinetti-Gbaguidi
et al., 2011; Oh et al., 2012). Therefore, understanding the
environmental conditions that govern monocyte recruitment
and subsequentmacrophage immune programming and choles-
terol deposition is key to the development of novel therapeutic
strategies.
ER stress is an important cellular adaptation linking immune
responses to obesity, insulin resistance, and atherosclerosis
(Hotamisligil, 2010). Stimulation of ER stress induces responses
to improve protein folding, but persistent stress triggers
further inflammation through NF-kB and c-Jun N-terminal
kinase (JNK) activation, increasing foam cell formation and
inducing plaque necrosis in advanced atherosclerotic lesionss
(Hotamisligil, 2006; Ozcan and Tabas, 2010). Vitamin D is a nat-
ural macrophage ER stress reliever (Riek et al., 2012). Vitamin D
receptor (VDR) is present in almost all cells of the immune sys-
tem, and vitamin D deficiency is widely prevalent and has
emerged as a potential contributor to the pathophysiology of
T2DM and CVD (Holick, 2007; Norman and Powell, 2014;
Veldman et al., 2000). Active vitamin D (1,25(OH)2D3) reduces
adipocyte monocyte recruitment and inflammatory responses,
improving adipocyte glucose uptake (Gao et al., 2013). In
contrast, diet-induced vitamin D deficiency in mice results in hy-
pertension and accelerated atherosclerosis due to increased
plaque ER stress (Weng et al., 2013). Similarly, total body VDR
knockout increases blood pressure and accelerates atherogen-
esis, possibly by local activation of the renin angiotensin system
in macrophages (Szeto et al., 2012). In vitamin-D-deficient dia-
betic patients, suppression of monocyte/macrophage ER stress
by activating VDR decreases adhesion to endothelial cells and
migration (Riek et al., 2012, 2013, 2014). Furthermore,
1,25(OH)2D3 suppresses macrophage cholesterol uptake and
foam cell formation through downregulation of ER stress and
subsequent reduction of JNK phosphorylation, peroxisome-pro-
liferator-activated receptor gamma (PPARg) expression, and
scavenger receptor CD36 and SR-A1 expression. Together,
these data suggest that regulation of ER stress by vitamin D
exerts a pivotal role in macrophage cholesterol deposition and
monocyte infiltration to critical metabolic tissues. This study
was designed to determine the in vivo effects of VDR deletion
on macrophage ER stress, chronic inflammation, insulin resis-
tance, and atherosclerosis.RESULTS
Efficiency of Macrophage VDR Deletion
Animals with specific inactivation of VDR in myeloid cells
(knockout of vitamin D receptor in macrophages; KODMAC)
were obtained by crossing Vdrfl/fl mice (Masuyama et al., 2006)
with transgenic mice expressing Cre recombinase under the
control of the lyzosomal M promoter (Lyz2Cre+/) in Ldlr/ or
Apoe/ backgrounds, models of diet-induced insulin resistance
and atherosclerosis, to produce KODMAC-L and KODMAC-E
mice, respectively (Figure 1A). All animals were fed chow diet
for 6 weeks after weaning, then high-fat diet (HFD) for an addi-
tional 8 weeks in Apoe/ and 10 weeks in Ldlr/ mice unless
otherwise specified.
The efficiency of macrophage-specific Vdr inactivation in
KODMAC-L was demonstrated with Vdr mRNA levels in bone-
marrow-derived macrophages (BMDM), peripheral blood mono-
cytes, and peritoneal macrophages and VDR protein levels in
multiple tissues (Figures 1B and 1C). Similar results were found
for KODMAC-E (data not shown). Incubation of KODMAC-L peri-
toneal macrophages with 1,25(OH)2D3 confirmed suppressed
expression of the VDR target gene Cyp24a1 (Figure 1D).
KODMAC-L mice had similar body weight and composition
compared to control littermates (control-L) (Figures 1E–1G).
Cholesterol and triglyceride levels were also similar before and
after HFD (Figures 1H and 1I). In contrast, fasting glucose was
higher in KODMAC-L before and after HFD (Figure 1J). Similar re-Cellsults were found in KODMAC-E mice in comparison to litter-
mates (control-E) (Figures S1A–S1D).
Deletion of Macrophage Vdr Induces Insulin Resistance
To characterize the altered glucose metabolism in KODMAC-L,
we performed glucose tolerance tests (GTTs) and insulin toler-
ance tests (ITTs) after 6 weeks on chow and after an additional
10 weeks of HFD. KODMAC-L developed glucose intolerance
before and after HFD with no compensatory increase in insulin
secretion (Figures 2A and S2A). In addition, KODMAC-L mice
were more resistant to glucose lowering by exogenous insulin,
suggesting insulin resistance (Figures 2B and S2B). KODMAC-E
also showed insulin resistance before and after 8 weeks on HFD
(Figures S2C–S2F). To clarify the primary site of insulin resis-
tance in KODMAC-L, we performed hyperinsulinemic-euglyce-
mic clamps in mice before HFD. KODMAC-L had significantly
reduced glucose infusion rate and increased hepatic glucose
production, with no difference in disposal rate, consistent with
increased hepatic gluconeogenesis (Figures 2C–2E). mRNA
expression of two key gluconeogenic enzymes, phosphoenol-
pyruvate carboxykinase (Pck1) and glucose 6-phosphatase
(G6pc), was higher in KODMAC-L hepatocytes (Figure 2F), and
hepatic AKT phosphorylation was diminished in KODMAC-L
mice after inferior vena cava insulin injection, confirming hepatic
insulin resistance (Figure 2G). To determine whether KODMAC-L
macrophages directly modulate hepatic glucose production, we
co-cultured primary hepatocytes from control-L mice with peri-
toneal macrophages from KODMAC-L or control-L and found
increased hepatocyte expression of Pck1 and G6pc after incu-
bation with KODMAC-L macrophages. Moreover, culture of
primary control-L hepatocytes with KODMAC-L macrophage
media recapitulated the induction of gluconeogenic enzymes
(Figure 2H), implying a macrophage secretory factor affecting
hepatic gluconeogenesis. Media from the KODMAC-L co-
culture had a higher concentration of tumor necrosis factor a
(TNF-a), IL-1b, and IL-6, all cytokines reported to induce hepatic
gluconeogenesis (Figure 2I). Liver histologic analysis showed
increasedmacrophage accumulation and cholesterol deposition
in KODMAC-L mice (Figures 2J–2L), suggesting increased cyto-
kine secretion from hepatic macrophage infiltration induces
gluconeogenic enzymes. We next explored the macrophage
subtype in KODMAC-L livers. Interestingly, KODMAC-L liver
macrophages showed an M2 pattern of membrane markers by
flow cytometry with a consistent M2 gene signature (Figures
2M, S2G, and S2H). To clarify whether the M2macrophage sub-
type differentiation was liver specific, we analyzed BMDM and
peritoneal macrophages from KODMAC-L mice, with all cells
demonstrating an M2 membrane and mRNA expression pattern
(Figures 2N, 2O, and S2I–S2L), suggesting that macrophage Vdr
deletion increased M2 macrophages and cytokine activation of
hepatic insulin resistance.
Deletion of Macrophage Vdr Increases Foam Cell
Formation and Accelerates Atherosclerosis
Macrophage infiltration and lipid accumulation in the vessel wall
are critical in atherosclerosis initiation and progression. In type 2
diabetics, active vitamin D promotes macrophage differentiation
in vitro and suppresses cytokine secretion (Giulietti et al., 2007).Reports 10, 1872–1886, March 24, 2015 ª2015 The Authors 1873
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To determine whether the immunomodulatory effects of macro-
phage VDR signaling play a role in atherosclerosis, wemeasured
atherosclerotic lesions in KODMACmice after HFD. KODMAC-L
and -E had 3-fold and 2-fold greater median plaque area,
respectively, in all aortic regions compared to control-L and con-
trol-E (Figures 3A and S3A) and toCre+/Ldlr/ littermates (data
not shown). Moreover, KODMAC-L and KODMAC-E mice on
prolonged chow diet only, without exposure to HFD, had 4- to
10-fold increased plaque area across all aortic regions (Figures
S3B and S3C), suggesting that defective macrophage VDR
signaling is critical to atherosclerosis progression.
Next, we explored whether alterations in KODMAC-L macro-
phage cholesterol metabolism contribute to increased athero-
sclerosis. Peritoneal macrophages from KODMAC-L mice after
10 weeks of HFD had increased foam cell formation by oil-
red-O staining and higher free and total cholesterol content (Fig-
ures 3B–3D). Foam cell formation was mediated by increasing
oxidized low-density lipoprotein (oxLDL) cholesterol binding
and uptake and cholesterol ester formation with no differences
in cholesterol efflux (Figures 3E–3H). To determine whether the
M1/M2 macrophage profile induced in KODMAC-L correlates
with the deposition of atherosclerotic plaque foam cells, we
examined frozen sections of the aortic root from KODMAC-L
mice after 10 weeks on HFD. Immunofluorescent staining re-
vealed increased vessel wall infiltration with predominantly M2
macrophages that co-localized with fat staining by adipose
differentiation-related protein (ADRP) compared to control-L,
consistent with our previous observation that M2 macrophages
induced by vitamin D deficiency accumulate more cholesterol
(Figures 3I–3K) (Weng et al., 2013).
CaMKII Links ERStress to IncreasedCholesterol Uptake
in KODMAC-L Macrophages
In diabetic patients, ER stress activation induced by vitamin
D deficiency triggers M2 macrophage differentiation and foam
cell formation by increasing scavenger-receptor-mediated
cholesterol uptake (Oh et al., 2009; Riek et al., 2013). Therefore,
we explored whether the effects of vitamin D on foam cell forma-
tion are ER stress-VDR-dependent in vivo. Consistent with our
previous data, peritoneal macrophages from KODMAC-L mice
after 6 weeks of chow showed upregulation of ER stress, JNK
phosphorylation, PPARg, and scavenger receptors CD36
and SRA-1, regardless of vitamin D conditions (Figure 4A).
KODMAC-L macrophages also demonstrated increased acety-
lated LDL cholesterol binding and uptake (Figures S4A and
S4B). We then confirmed that the effects of Vdr deletion on
macrophage subtype are ER-stress-dependent. Incubation ofFigure 1. Deletion of Vdr in Macrophages in Ldlr/ Mice
(A) Schematic representation of generation of KODMAC mice.
(B) qRT-PCR analysis of relative VdrmRNA expression normalized toMrpl32 expr
group).
(C) Western blot analysis of VDR from KODMAC-L and control-L tissues.
(D) qRT-PCR analysis of Cyp24a1 mRNA expression normalized to Mrpl32 in c
108 M (n = 6 per group).
(E) Weight before and after high-fat diet (HFD) (n = 16–20 per group).
(F and G) Body fat (F) and lean body mass (G) percentage after HFD (n = 18–20
(H–J) Fasting serum (H) cholesterol, (I) triglycerides, and (J) glucose before and a
*p < 0.05 versus control-L. Data are presented as mean ± SEM. See also Figure
CellKODMAC-L macrophages with an ER stress inhibitor, 4-phenyl-
butyrate (PBA), shifted them toward an M1 expression pattern
similar to that of control-L cells (Figures S4C and S4D). In previ-
ous studies in cholesterol-loaded macrophages, increased
cytosolic calcium resulting from ER stress activates calmod-
ulin-dependent protein kinase II (CaMKII), linking ER stress to
JNK-mediated macrophage apoptosis (Timmins et al., 2009).
We studied type 2 diabetic human macrophages cultured in
vitamin-D-deficient or 1,25(OH)2D3-supplemented conditions
and chow-fed KODMAC-L or control-L peritoneal macro-
phages to explore whether CaMKII activation links impaired
vitamin D signaling to macrophage cholesterol uptake. Both
KODMAC-L and vitamin-D-deficient human macrophages had
increased CaMKII phosphorylation compared to control-L or
1,25(OH)2D3-supplemented human macrophages, respectively,
but no differences in total CaMKII expression (Figure 4B). To
determine the effects of CaMKII inhibition on macrophage
cholesterol uptake, we used KN-93, a CaMKII inhibitory agent,
in KODMAC-L and control-L peritoneal macrophages under
vitamin-D-deficient or 1,25(OH)2D3-supplemented conditions.
Vitamin-D-deficient control-L macrophages and KODMAC-L
macrophages in both vitamin D conditions all had significantly
higher oxLDL cholesterol uptake compared to 1,25(OH)2D3-sup-
plemented control-L macrophages, but CaMKII inhibition abol-
ished this increased cholesterol uptake in all circumstances
(Figure 4C), suggesting that CaMKII activation is key in
macrophage cholesterol uptake induced by defective vitamin
D signaling. Moreover, inhibiting CaMKIIp in KODMAC-L or
control-L macrophages under vitamin-D-deficient conditions
suppressed JNKp, PPARg, CD36, and ER stress (Figure 4D),
suggesting that activation of CaMKII links vitamin-D-defi-
ciency-induced ER stress to JNK-mediated macrophage
cholesterol uptake.
VDR Signaling Facilitates SERCA2b Function
and Suppresses ER Stress
Sarcoendoplasmic reticulum calcium ATPase 2b (SERCA2b) is a
critical enzyme maintaining high ER calcium levels to optimize
protein production and folding. Induction of macrophage ER
stress by the SERCA inhibitor thapsigargin in control-L macro-
phages shifts macrophages toward an M2 expression pattern
similar to that of KODMAC-L (Figures S4E and S4F), implying
similar effects of Vdr deletion and SERCA dysfunction. To clarify
whether Vdr deletion induces ER stress by changing SERCA2b
expression or function, we again studied peritoneal macro-
phages from KODMAC-L and control-L mice after 6 weeks of
chow and human type 2 diabetic macrophages cultured inession in CD11b+ BMDMs, monocytes, and peritoneal macrophages (n = 3 per
ultured peritoneal macrophages with or without stimulation with 1,25(OH)2D3
per group).
fter HFD (n = 12 per group).
S1.
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Figure 2. Deletion of Macrophage Vdr Induced Insulin Resistance
KODMAC-L and control-L mice after 6 weeks of chow were assessed for glucose metabolism and insulin resistance after overnight fast.
(A and B) Glucose tolerance test (A) with 30-min plasma insulin levels (inset) (n = 35 per group) and (B) insulin tolerance test (B) (n = 16 per group).
(C–E) From hyperinsulinemic euglycemic clamps, (C) glucose infusion rate, (D) hepatic glucose production after insulin stimulation, and (E) glucose disposal rate
(n = 7–8 per group).
(F) qRT-PCR analysis of relative Pck1 and G6pc mRNA expression from hepatocytes, normalized to Mrpl32 (n = 6 per group).
(G) Western blot analysis of phosphorylated AKT from hepatocytes (n = 3 per group).
(legend continued on next page)
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vitamin-D-deficient or 1,25(OH)2D3-supplemented conditions.
We found no differences in SERCA2b protein expression
among all groups (Figure 4B). However, SERCA2b activity in
KODMAC-L and vitamin D-deficient human macrophages
was decreased by at least 20% compared to control-L and
1,25(OH)2D3-supplemented macrophages, respectively, sug-
gesting that VDR activates SERCA2b to maintain normal ER
functionality (Figures 4E and 4F). To confirm the effects of
deletion of macrophage VDR on SERCA2b function in diabetic
patients, we infected human macrophages cultured in
1,25(OH)2D3-supplemented media with lentivirus containing
either small interfering RNA (siRNA) VDR hairpins or control
siRNA. VDR-siRNA-infected macrophages showed significantly
lower SERCA2b activity compared to control-siRNA-infected
macrophages (Figure 4G). Finally, we immunoprecipitated
KODMAC-L and control-L peritoneal macrophage lysates with
VDR antibody and blotted for SERCA2b, identifying expression
in control-L cells, but not KODMAC-L cells, suggestive of VDR-
SERCA2b interaction (Figure 4H). Co-localization of SERCA2b
with VDR by immunofluorescence in control-L peritoneal macro-
phages confirmed a mechanism of VDR interaction with
SERCA2b to optimize ER function (Figures 4I and 4J).
Deletion of VDR Signaling Enables Monocyte
Cholesterol Transport into the Atherosclerotic Plaque
Monocyte adhesion to the endothelium and migration into the
subendothelial space are critical to atherosclerotic plaque
macrophage deposition and foam cell formation (Gautier et al.,
2009). However, recent studies suggest that non-classical
monocytes can become cholesterol laden in the circulation
andmay be a potential source of vascular cholesterol deposition
in addition to differentiated plaque macrophages (Mosig et al.,
2009; Wu et al., 2009). We evaluated cholesterol content in
KODMAC-L circulating monocytes after 3 weeks of HFD,
demonstrating higher cholesterol content and oxLDL uptake
(Figures 5A and 5B). Moreover, KODMAC-L monocytes demon-
strated higher adhesion to fibronectin and increased migration in
response to monocyte chemoattractant protein 1 (MCP-1) and,
accordingly, increased mRNA expression of adhesion mem-
brane receptor b1 integrin and MCP-1 receptor (CCR2) (Figures
5C, 5D, S5A, and S5B), indicating that Vdr deletion induces a
pro-atherogenic phenotype that might enable monocytes to
carry cholesterol into the atherosclerotic plaque. To study this
potential mechanism directly, we incubated KODMAC-L or
control-L monocytes from mice after 6 weeks of chow with sta-
bly labeled, non-naturally occurring cholesterol-d7 and infused
them into chow-fed 6-month-old LDLR/ recipient mice to
determine if cholesterol-d7 was detectable in the recipient(H) qRT-PCR analysis of relative Pck1 and G6pc mRNA expression from contro
media, normalized to Mrpl32 (n = 6 per group).
(I) Cytokine concentrations from co-culture media (n = 4 per group).
(J) H&E stain (left panels) and F4/80 immunohistochemistry (right panels) of liver (re
represents 250 mm (100 mm for inset).
(K) Percentage of F4/80-positive cells by manual counting of light microscopy fie
(L) Liver macrophage cholesterol content (n = 6 per group).
(M–O) Flow cytometry expression ofmembraneM1markers CCR7 andCD86 and
(O) peritoneal macrophages (n = 4 per group).
*p < 0.05 versus control-L. Data are presented as mean ± SEM. See also Figure
Cellmouse aorta.We first confirmed cholesterol-d7 uptake into cells.
As expected, KODMAC-L monocytes had nearly doubled
cholesterol-d7 esterification compared to control-L monocytes
(Figure 5E). After transfusion, we found minimal enrichment of
cholesterol-d7 in the plasma at multiple time points up to 24 hr,
suggesting that cholesterol efflux out of monocytes was not a
significant contributor to vessel wall cholesterol-d7 deposition
(data not shown). Strikingly, 24 hr after infusion, aortas from
mice receiving KODMAC-L monocytes had 150-fold higher
enrichment of cholesterol-d7 compared to plasma and more
than 3-fold higher enrichment than control-L monocyte recipient
aortas (Figure 5F), suggesting that monocyte cholesterol trans-
port into the vessel wall may explain the increased atheroscle-
rosis in KODMAC-L. We confirmed this monocyte capability
with an additional experiment where we isolated CD11b+ mono-
cytes from KODMAC-L mice after 6 weeks on chow, incubated
with labeled DiI-oxLDL cholesterol, and infused them daily for
3 days into high-fat-fed LDLR/mice. Two-photon microscopy
from explanted aortas showed localization of DiI-oxLDL inside
the vascular wall in the subendothelial space, implying accumu-
lation of lipid-laden monocytes (Figure 5G), confirming an LDL-
independent pathway for vascular cholesterol deposition.
To characterize the circulating monocytes associated with
cholesterol deposition in KODMAC-L, we used flow cytometry
to evaluate traditional murine monocyte markers. Monocytes
from KODMAC-L mice after 3 weeks of HFD had significantly
more Ly6clo cells and fewer Ly6c cells compared to control-
L cells. However, there was no difference in Ly6chi cells between
the groups. In addition, there were significantly more cells pos-
itive for CCR2 in KODMAC-L, and this was driven by the shift
toward Ly6clo cells (Figure 5H), suggesting that deletion of
VDR induces a non-classical subtype of monocytes that
express membrane markers facilitating vascular invasion. In
our previous work, M1/M2 macrophage markers assessed in
diabetic monocytes correlate better with adhesion and migra-
tion than the typical markers used to classify human monocytes
(CD14/CD16). Therefore, we tested whether the M1/M2 expres-
sion phenotype of circulating monocytes would reflect the
early plaque macrophage subtype. KODMAC-L monocytes ex-
pressed predominantly M2 membrane markers with mRNA
expression typical of M2 polarization (Figures 5I, S5C, and
S5D). Frozen sections of early atherosclerotic plaques in the
aortic root from KODMAC-L mice after 3 weeks on HFD also
showed a predominance of M2 macrophages with more
ADRP co-localization compared to M1 macrophages (Figures
5J–5L), similar to KODMAC-L after HFD. Therefore, deletion of
monocyte VDR promotes a pro-atherogenic M2 monocyte
phenotype, resulting in M2-predominant plaque macrophagesl hepatocytes co-cultured with KODMAC-L or control-L macrophages or their
presentative of n = 3 per group). Arrows showmacrophage infiltrates. Scale bar
lds (n = 3 per group).
M2markersMR andCD163 in (M) CD11b+ liver macrophages, (N) BMDMs, and
S2.
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Figure 3. Deletion of Macrophage Vdr Accelerated Atherosclerosis
KODMAC-L and control-L mice were assessed for atherosclerosis and macrophage cholesterol metabolism after HFD.
(A) Atherosclerotic plaque area of pinned aortas (n = 16 per group). Lines indicate median values.
(B–H) In peritoneal macrophages, (B) representative image of oil red O staining (scale bar represents 10 mm), (C) free and (D) total cholesterol content (n = 6 each
group), (E) cholesterol binding and (F) cholesterol uptake after stimulation with DiI-oxLDL for 6 hr, (G) cholesteryl ester formation after stimulation with oxLDL
and 3H oleic acid for 6 hr, and (H) cholesterol efflux after incubation with 3H cholesterol for 24 hr and stimulation with HDL or apolipoprotein AI for 6 hr (n = 6 per
group). *p < 0.05 versus control-L for (A)–(H).
(legend continued on next page)
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with increased cholesterol deposition that persist throughout
plaque progression.
Cardiometabolic Abnormalities from Vdr Deletion Are
Transplantable
To determine whether introduction of normal macrophage VDR
signaling by bone marrow (BM) transplant could prevent meta-
bolic dysregulation and atherosclerosis in KODMAC-L, we trans-
planted previously irradiated KODMAC-L mice with BM from
KODMAC-L (KOD/KOD) or control-L (Con/KOD) animals. After
6 weeks of chow diet, Con/KOD mice had decreased fasting
glucose, improved insulin sensitivity with decreased expression
of hepatic gluconeogenic enzymes, and liver macrophages
shifted toward an M1-predominant phenotype (Figures 6A–6D).
After HFD, Con/KOD mice also had increased insulin sensitivity
(Figures S6A–S6C) and decreased atherosclerotic area in the
proximal and thoracic aorta compared to KOD/KOD (Figure 6E).
Moreover, peritoneal macrophages had decreased cholesterol
uptake and cholesteryl ester formation with no differences in
cholesterol efflux (Figures 6F–6H). Conversely, we transplanted
control-L mice with BM from KODMAC-L (KOD/Con) or
control-L (Con/Con) animals to induce the metabolic phenotype.
As expected, KOD/Con mice demonstrated cardiometabolic
dysregulation compared to Con/Con, with increased glucose
levels, insulin resistance, atherosclerosis, M2 macrophages,
and foam cell formation with greater cholesterol uptake (Figures
6I–6P and S6D–S6F). There was no differential effect of BM
transplantation on fasting cholesterol or triglycerides (Figures
S7G–S7J). These data confirm the fundamental role of macro-
phage VDR signaling in chronic inflammation, affecting meta-
bolic function and atherosclerosis progression.
DISCUSSION
Little is known about environmental immunomodulators
affecting the chronic inflammation in metabolic tissues that
contribute to vascular disease. In this work, we demonstrate
that Vdr deletion in a single cell lineage in KODMAC mice is
sufficient to induce insulin resistance and accelerate atheroscle-
rosis. KODMAC-L mice had accelerated M2 macrophage
infiltration and cholesterol deposition in the liver, increasing cyto-
kine secretion and hepatic glucose production. Moreover,
KODMAC-L animals were predisposed to plaque cholesterol
deposition via both M2 monocyte transport of cholesterol into
the vessel wall and cholesterol uptake by M2 plaque macro-
phages. Increased cholesterol deposition precipitated by
impaired VDR-SERCA interaction induced ER stress activation
of CaMKII, triggering the JNK-PPARg pathway and upregulation
of scavenger receptors CD36 and SR-A1 to facilitate foam
cell formation. BM transplant of VDR-expressing cells into
KODMAC-L mice improved insulin sensitivity, decreased foam
cell formation, and suppressed atherosclerosis, confirming the(I) Immunofluorescent staining for ADRP to identify lipid droplets (red, left column),
(yellow, right column) in the proximal aorta after HFD. Blue shows nuclei stained
(J and K) Quantification of CCR7 and MR as a percentage of total plaque area (
centage of total ADRP co-localizing with CCR7 or MR (K) (n = 6 per group).
*p < 0.05 versus same receptor in KODMAC-L; **p < 0.05 versus KODMAC-L CC
Cellcritical role of macrophage VDR signaling in diet-induced insulin
resistance and atherosclerosis.
Previous evidence reveals the role of liver macrophage infiltra-
tion in hepatic insulin resistance. In rats, selective depletion of
liver-resident macrophages enhances hepatic insulin sensitivity
after HFD (Lanthier et al., 2010). In mice, macrophage ablation
of an upstream activator of NF-kB enhances hepatic and periph-
eral insulin sensitivity (Arkan et al., 2005). Accordingly, we found
that deletion of macrophage Vdr increased monocyte adhesion
andmigration, promoting hepatic cholesterol deposition, macro-
phage accumulation, and glucose production through cytokine
release. Interestingly, hepatic macrophage subtypes also play
a key role in hepatic gluconeogenesis. BM transplant from
mice deficient for Ppard, a transcription factor that facilitates
IL-4-induced M2 macrophage differentiation, causes hepatic
infiltration and increased gluconeogenesis (Odegaard et al.,
2008). In contrast, we found that deletion of macrophage Vdr
favors hepatic accumulation of M2 cells that stimulate gluconeo-
genesis. The transplantability of this phenotype confirms that
VDR signaling links macrophage subtype to hepatic gluconeo-
genesis. These contrasting findings imply that the M1-M2 para-
digm to describe the inflammatory profile of macrophage
subtypes as they contribute to hepatic insulin resistance may
be oversimplified.
The recruitment of circulatingmonocytes into the vessel wall is
critical in the pathophysiology of vascular complications (Hans-
son and Hermansson, 2011). Recent studies in patients with
familial hypercholesterolemia and in mouse models of athero-
sclerosis show that non-classical monocytes can become
cholesterol laden in the circulation, suggesting they may carry
cholesterol into the vessel wall (Mosig et al., 2009; Wu et al.,
2009). We found that VDR signaling regulates atherosclerosis
initiation by modifying circulating monocyte cholesterol trans-
port and plaquemacrophage phenotype. Monocyte Vdr deletion
induced a cholesterol-laden M2 phenotype with increased
adhesion to and migration into the vessel wall, facilitating an
LDL-independent pathway for cholesterol transport into the early
atherosclerotic plaque.
Macrophages are key cells in atherosclerosis progression. The
cellular microenvironment directs macrophages into different
subtypes with distinct cholesterol metabolism phenotypes. In
IL-4-induced M2 macrophages, CD36 signaling activation by
long-chain free fatty acids generates small lipid droplets and
increased b-oxidation (Huang et al., 2014). In contrast, CD36
signaling activation by oxLDL results in increased cholesterol
deposition and nuclear sequestration of AMPK, diminishing
b-oxidation (Oh et al., 2009; Samovski et al., 2015). In vivo, the
location of M2 macrophages in atherosclerotic plaque affects
cholesterol metabolism. Increased IL-4 overlying the lipid core
induces M2 macrophages (CD68+ and MR+) with increased
cholesterol ester formation, reduced cholesterol efflux, and
small lipid droplets (Chinetti-Gbaguidi et al., 2011). In contrast,M1marker CCR7 orM2markerMR (green, middle column), and co-localization
with DAPI. Scale bar represents 50 mm.
J) and lipid co-localization with M1 or M2 macrophages assessed as the per-
R7. Data are presented as mean ± SEM. See also Figure S3.
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Figure 4. Deletion of Macrophage Vdr Increased ER Stress and Accelerated Cholesterol Uptake by Activation of the CaMKII Signaling
Pathway
Peritoneal macrophages fromKODMAC-L or control-L before HFD and/or humanmonocyte-derivedmacrophages from type 2 diabetics were cultured for 5 days
in vitamin-D-deficient or 1,25(OH)2D3-supplemented conditions.
(A) Western blot of ER stress and cholesterol signaling proteins.
(legend continued on next page)
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in areas of previous intraplaque hemorrhage, M2 macrophages
(MR+ and CD163+) produce IL-10 and have increased choles-
terol efflux and lower cholesterol content (Finn et al., 2012),
highlighting the effect of the microenvironment on the interplay
between macrophage subtype and functionality. In our study,
KODMAC-L mice had increased atherosclerosis with a
persistent predominance of cholesterol-laden M2 cells as pla-
ques progressed. Similar results of increased atherosclerosis
have been demonstrated in Vdr total knockout mice; these ani-
mals also have increased ex vivo macrophage foam cell forma-
tion in response to modified LDL cholesterol (Szeto et al.,
2012). Our model shows that deletion of VDR is sufficient to
program a sustained, pro-atherogenic monocyte/macrophage
phenotype, confirmed by the transplantability of the cardiometa-
bolic outcomes.
Chronic excess of cytokines, glucose, and lipids triggers ER
stress, provoking inflammatory signaling, macrophage choles-
terol uptake, or macrophage death, key mechanisms in insulin
resistance and atherosclerosis (Hummasti and Hotamisligil,
2010; Oh et al., 2012; Tabas and Ron, 2011). Vitamin D acts
as an ER stress reliever that suppresses pro-atherogenic
macrophage properties and decreases atherosclerosis. This
work demonstrates that the macrophage VDR interacts with
SERCA2b to improve its function, identifying a mechanism by
which vitamin D decreases ER stress. Macrophage accumula-
tion of modified lipids impairs SERCA2b expression, increasing
cytosolic calcium activation of the CaMKII-JNK pathway to
cause macrophage apoptosis and plaque instability (Liang
et al., 2012; Timmins et al., 2009). Similarly, we found thatmacro-
phage VDR signaling activation diminished CaMKII-JNK activa-
tion and suppressed cholesterol accumulation to break the cycle
of ER stress activation.
We recognize that the KODMAC model of Vdr deletion in
monocyte/macrophages is an extreme model of vitamin D
deficiency and may not directly represent animal and human
physiology. However, in animal models of insulin resistance
and in patients with T2DM, adequate dietary vitamin D also
promotes a monocyte/macrophage phenotype with lower
adhesion, migration, and foam cell formation, as well as
decreasing atherosclerosis (Oh et al., 2009; Riek et al., 2012;
Weng et al., 2013). It is also important to acknowledge that
these metabolic changes induced by macrophage-specific
Vdr deletion might represent just a component of the myriad
of cardiometabolic effects linked to vitamin D deficiency in
humans, such as hypertension, thrombosis, and systemic
inflammation. However, the KODMAC model highlights that(B) Western blot of SERCA2b and CaMKII activation (representative of n = 4 per
(C) Cholesterol uptake after DiI-oxLDL stimulation in murine macrophages with or
versus all others without KN-93; **p < 0.05 versus the same cells without KN-93
(D) Western blot of activated CaMKII and JNK, PPARg, CD36, and ER stress prote
per group).
(E–G) SERCA2b activity from (E) murinemacrophages cultured in 1,25(OH)2D3-sup
D-deficient or 1,25(OH)2D3-supplemented conditions (n = 5 per group), and (G)
infected with Vdr-siRNA or control siRNA (n = 5 per group) (*p < 0.05 versus con
(H and I) SERCA2b expression in murine control-L macrophage lysates immuno
(green, left), SERCA2b (red, middle), and co-localization (yellow, right) in murine
(J) Schematic depicting VDR-driven modulation of SERCA2b activity and induct
Data are expressed as mean ± SEM. See also Figure S4.
CellVDR-dependent signaling in a single cell linage is a critical
pathway integrating inflammation, insulin resistance, and
atherosclerosis.
EXPERIMENTAL PROCEDURES
Additional details and references are provided in the Supplemental Experi-
mental Procedures.
Experimental Models
Vdrfl/fl mice were backcrossed into C57BL/6 for ten generations (Masuyama
et al., 2006). Inactivation of VDR in myeloid cells (KODMAC) was generated
by crossing Vdrfl/fl mice with transgenic mice expressing Cre recombinase
under the control of the lyzosomal M promoter (Lyz2Cre+/) in Ldlr/
(KODMAC-L) or Apoe/ (KODMAC-E) backgrounds. Littermate mice
Lyz2Cre/Vdrfl/flLdlr/ mice (control-L) and Lyz2Cre/Vdrfl/flApoe/
(control-E) were used as controls. Mice received normal chow diet (Harlan
TD87095) for 6 weeks after weaning, then vitamin D-sufficient HFD for
8 weeks in the Apoe/ and for 10 weeks in the Ldlr/ background (Harlan
TD88137). Additional mice were maintained on chow for 1 year for athero-
sclerosis assessment. For BM transplants, lethally irradiated 8-week-old
chow-fed KODMAC-L or control-L recipient mice were reconstituted
with 5 3 106 BM cells from 8-week-old chow-fed KODMAC-L or control-
L mice via injection. Recipient mice were given 6 weeks of chow, then
10 weeks of HFD. All experiments included male and female animals and
were approved by the Washington University Animal Studies Committee.
Adult subjects with T2DM were voluntarily recruited and provided with
written informed consent, approved by the Human Research Protection
Office of Washington University School of Medicine.
Isolation of Murine Peritoneal, Hepatic, and BMDMs and Peripheral
Monocytes
Peritoneal macrophages were collected immediately following injection of
PBS into the peritoneum and cultured for 3 hr in vitamin-D-deficient media
(deficient in both 25(OH)D and 1,25(OH)2D; obtained by DMEM plus 10%
charcoal/dextran-treated FBS) with or without 1,25(OH)2D3 (Sigma-Aldrich,
108 M) prior to assessment. Cells were subjected to CD11b microbeads
(Miltenyi Biotec) prior to flow cytometry. For hepatic macrophage isolation,
livers were resected, minced, treated with collagenase, and filtered (70-mm
cell strainer, BD Bioscience) to remove hepatocytes. Hepatic macrophages
were selected for CD11b (present in macrophages, but not Kupffer cells)
with microbeads. For BMDMs, BM was flushed from femurs and tibias and
subjected to erythrocyte lysis, then CD11b microbeads prior to 5 days of cul-
ture with 100 ng/ml of macrophage colony stimulating factor (M-CSF) in
vitamin-D-deficient media plus 1,25(OH)2D3 (10
8 M). Peripheral blood mono-
cytes were selected by CD11b microbeads and stabilized for 3 hr in DMEM
plus 10% serum from the original mouse to mimic in vivo conditions prior to
any procedures.
Isolation of Human Monocyte-Derived Macrophages
Peripheral monocytes were isolated by standard Ficoll isolation techniques
and selected by CD14 microbeads (Miltenyi Biotec) with CD14+/CD11b+ cellgroup).
without CaMKII inhibitor KN-93 for 6 hr (n = 7 per group) (*p < 0.001 by ANOVA
).
in CHOP in murine macrophages with or without KN-93 (representative of n = 4
plementedmedia (n = 4 per group), (F) humanmacrophages cultured in vitamin
human macrophages cultured in 1,25(OH)2D3-supplemented conditions and
trol-L or vitamin D supplemented for all).
precipitated with VDR antibody (H), and immunofluorescent staining for VDR
control-L macrophages (I). Scale bar represents 10 mm.
ion of foam cell formation.
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Figure 5. Deletion of Macrophage Vdr Increased Lipid-Laden M2 Cells in the Atherosclerotic Plaque
(A–D) Peripheral blood monocytes from KODMAC-L and control-L mice after 3 weeks of HFD were assessed for (A) total cellular cholesterol (n = 6 per group),
(B) cholesterol uptake after DiI-oxLDL stimulation for 6 hr (n = 4 per group), (C) adhesion to fibronectin (n = 6 per group), and (D) transwell migration in response to
MCP-1 stimulation (n = 12 per group).
(E and F) KODMAC-L and control-Lmonocytes were incubatedwith stably labeled cholesterol-d7 for 24 hr and transfused into 6-month-old Ldlr
/mice on chow.
Cholesterol-d7 ester enrichment in (E) monocytes (n = 5 per group) and (F) aortic arch relative to plasma (n = 3 per group).
(legend continued on next page)
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purity of 97% by flow cytometry (FACStar Plus). For monocyte-derivedmacro-
phages, monocytes were cultured with 100 ng/ml of M-CSF for 5 days in
vitamin-D-deficient media with or without supplementation of 1,25(OH)2D3
(108 M). For ER stress suppression or induction, differentiated macrophages
were cultured with PBA (10 mM) or thapsigargin (0.25 mM), respectively, for an
additional 18 hr. For lentiviral infection, after 5 days of differentiation in
1,25(OH)2D3-supplemented conditions, macrophages were infected with
lentivirus containing either Vdr-siRNA or control-siRNA, with assays per-
formed 72 hr later.
Metabolic Assessment
Mice underwent metabolic characterization after 6 weeks of chow and after an
additional 8–10 weeks of HFD (Apoe/ or Ldlr/ background, respectively).
Body composition was performed by dual energy X-ray absorptiometry
(PIXImus,GECorporation). Serumglucose,cholesterol, and triglyceridesand in-
sulin were measured after 6 hr of fasting using commercially available kits. For
GTTs and ITTs, mice were fasted overnight prior to peritoneal injection with
10%D-glucose (1 g/kg) or insulin (0.75 U/kg, Humulin R). Hyperinsulinemic eu-
glycemic clamps were performed in conscious mice after 6 hr of fasting with a
clampedglucose level of 120mg/dl. For hepatic insulin signaling, liverswere iso-
latedandsnap frozen2minafter inferior venacava insulin injection in fastedmice
and were then homogenized and immunoblotted for phospho-AKT (Ser473).
Hepatocyte Isolation and Macrophage Co-culture
Livers of anesthetized 8-week-old control-L mice were perfused with
collagenase-containing media (Invitrogen) and resected. The dissociated he-
patocytes were allowed to recover for 24 hr. Peritoneal KODMAC-L and
control-L macrophages were cultured for 24 hr in 1,25(OH)2D -supplemented
media prior to co-culture onto hepatocyte cultures at a 1:2 macrophage:
hepatocyte ratio for 18 hr. TNF-a (BD Biosciences) and IL-1b and IL-6 (R&D
Biosystems) concentrations were measured by ELISA in co-culture media.
For liver histology, sections of frozen livers were stained with H&E or with
macrophage-specific antibody F4/80 (1:100, Santa Cruz Biotechnology).
Nuclei were manually counted and cells were identified as positive or negative
for F4/80 in ten fields at 103 magnification per animal.
Flow Cytometry
Monocytes and hepatic, BM-derived, and peritoneal macrophages were
selected for CD11b with microbeads, then stained with antibodies directed
against CCR7, CD86, Ly6C, and CD115 (eBioscience), CD163 (Bioss USA),
and MR and CCR2 (R&D Systems). Monocytes and macrophages were gated
for live cells, and monocytes were additionally gated for CD115+ for analysis.
Murine Atherosclerosis
For atherosclerosis, aortae were prepared using the en face technique, with re-
sults reported as percentage involvement of the arch, thoracic, and abdominal
regions as analyzed using Image J. For co-localization of plaquemacrophages
with cholesterol deposition, cryosections of the aortic root were stained with
antibodies specific for CCR7 (M1 marker) or MR (M2 marker) and ADRP.
Plaque M1 or M2 macrophages were assessed as the percentage of total pla-
que area with staining for CCR7 or MR. Lipid co-localization with M1 or M2
macrophages was measured by the percentage of total ADRP-staining area
co-localizing with staining for CCR7 or MR.(G) Representative image of cross-section of aortic plaque by two-photon micro
oxLDL-cholesterol-incubated KODMAC-L monocytes. Red shows DiI-oxLDL, gre
bar represents 100 mm.
(H and I) From peripheral monocytes, flow cytometry expression of (H) monocytem
M2 markers (CD163 and MR) (n = 4 per group).
(J) Representative image of immunofluorescent staining for ADRP to identify lipid
column), and co-localization (yellow, right column) in the proximal aorta after 3 we
(K and L) Quantification of immunostaining of the proximal aorta for (K) M1 and M2
localization with M1 or M2 macrophages assessed as the percentage of total AD
receptor in KODMAC-L; **p < 0.05 versus KODMAC CCR7.
*p < 0.05 versus control-L for (A)–(I). Data are presented as mean ± SEM. See al
CellCellular Cholesterol Metabolism
Foam cell formation was assessed with fixation and staining with oil red O. For
cellular total or free cholesterol, lipids were extracted with chloroform:
methanol (1:2 v/v), dried, and reconstituted for enzymatic assays using com-
mercial reagents. For cholesterol binding and uptake, cells were incubated
for 6 hr with 10 mg/ml DiI-labeled oxidized LDL (DiI-oxLDL) at 4C (binding)
or at 37C (binding and uptake), with uptake calculated as the difference.
For cholesterol uptake assessments with CaMKII inhibitor KN93, macro-
phages were incubated with KN93 (10 mM) for 24 hr with DiI-oxLDL added
for the final 6 hr. For cholesterol ester, macrophages were incubated with
oxLDL (200 mg/ml) with 3H oleic acid (0.1 mM) for 6 hr prior to lipid extraction
and radioactivity assessment. For cholesterol efflux, macrophages were incu-
bated with oxLDL (100 mg/ml) with 5 mCi of 3H cholesterol for 24 hr, then with
apolipoprotein AI (25 mg/ml) or HDL (50 mg/ml) for 6 hr, after which supernatant
and cells were assessed for radioactivity.
SERCA2b Activity
SERCA2 activity was assayed by isolating macrophage ER fractions with dif-
ferential centrifugation, incubating with radiolabeled CaCl2 for 15 min at 37C,
and measuring radioactivity.
Immunofluorescence
Peritoneal macrophages were fixed on slides with 4% formalin, blocked with
5% goat serum, and incubated with SERCA2 (1:250, Abcam) and VDR
(1:200, Santa Cruz) overnight, then incubated with secondary antibody 488-
conjugated goat anti-rat (green) and 539-conjugated goat anti-rabbit (red).
Images were captured on a confocal microscope (Olympus Fv1000).
Monocyte Adhesion and Migration
Monocytes were added to fibronectin-coated plates and incubated for 4 hr at
37C before adhered cells were stained and quantified. Transwell migration
assays were performed by addition of monocytes to the upper chamber with
8 hr of MCP-1 (100 ng/well) stimulation in the lower chamber. Cells migrated
into the lower chamber were manually counted.
Monocyte Cholesterol Transport
The deuterium-labeled cholesterol-d7 tracer was added to 20% Intralipid,
generating a cholesterol-d7-containing emulsion. Monocytes were incubated
with the emulsion for 6 hr prior to infusion into recipient mice. Neutral lipids
from monocytes; plasma at 6, 12, and 24 hr; and recipient aortas at 24 hr
after infusion were extracted with chloroform:methanol (1:2 v/v). Underivat-
ized sterols were injected into a Thermo TSQ 8000 GC/MS/MS instrument
for quantification. Monocyte cholesterol enrichment as the ratio of choles-
terol-d7/natural cholesterol ester and aortic cholesterol ester enrichment
relative to the plasma cholesterol-d7/natural cholesterol ester were reported.
Two-photon microscopy was performed by the In Vivo Imaging Core at
Washington University. Aortic explants from mice after infusions with
DiI-oxLDL-incubated monocytes were placed in CO2-independent medium
and stained with anti-CD31. Optical sections were acquired by taking 60
sequential z steps at 2.5 mm spacing, with each plane representing an image
of 220 mm (x) by 240 mm (y) (at 2 pixels/mm). Imaging was performed using a
custom-built video-rate 2P microscope equipped with a Chameleon Vision II
Ti:Sapphire laser.scopy from HFD-fed Ldlr/ mice after 3 days of daily transfusions with DiI-
en shows CD31+ endothelium, and blue showsmatrix autofluorescence. Scale
arkers Ly6C andCCR2 and (I) macrophageM1markers (CCR7 and CD86) and
droplets (red, left column), M1 marker CCR7 or M2 marker MR (green, middle
eks of HFD. Blue shows nuclei stained with DAPI. Scale bar represents 50 mm.
macrophage markers as a percentage of total plaque area and for (L) lipid co-
RP co-localizing with CCR7 or MR (n = 6 per group). *p < 0.05 versus the same
so Figure S5.
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Figure 6. Deletion of Macrophage Vdr Was Sufficient to Induce Insulin Resistance and Atherosclerosis
Irradiated KODMAC-L mice were transplanted with BM from KODMAC-L (KOD/KOD) or control-L (Con/KOD) animals to rescue the phenotype (A–H), and
irradiated control mice were transplanted with BM from KODMAC-L (KOD/Con) or control-L (Con/Con) animals to induce the phenotype (I–P). All experiments
except (E) and (M) were performed before HFD.
(A and I) Glucose tolerance test with 30-min plasma insulin levels (inset) and (B and J) insulin tolerance test (n = 7–11 per group).
(C and K) qRT-PCR analysis of relative Pck1 and G6pc mRNA expression from hepatocytes, normalized to Mrpl32 (n = 3 per group).
(D and L) Flow cytometry expression of membrane M1 and M2 markers in liver macrophages (n = 4 per group).
(E and M) Atherosclerotic plaque area of pinned aortas after HFD (n = 8–11 per group).
(legend continued on next page)
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Gene Expression
qRT-PCR was performed using the TaqMan or SYBR Green reagent kit, with
relative expression levels of mRNAs calculated by the comparative threshold
cycle method using L32 (Mrpl32) as an internal control.Immunoblotting and Immunoprecipitation
Cellular proteins were immunoblotted for VDR (Santa Cruz), ER stress proteins
(pPERK and PERK [Cell Signaling], CHOP [Santa Cruz]), proteins involved in
cholesterol signaling (JNKp [Cell Signaling], PPARg, CD36, and SR-A1 [Santa
Cruz]), SERCA2 (Abcam), and pCAMKII and CAMKII (Cell Signaling), and
b-actin (Cell Signaling) was used as a loading control. For immunoprecipita-
tion, macrophage lysates from control-L mice after 6 weeks of chow were
incubated with monoclonal anti-VDR (Abcam), then blotted with anti-SERCA2
(Abcam).Statistical Analysis
Experiments were carried out in duplicate or triplicate. Parametric data are ex-
pressed as the mean ± SEM and analyzed by t tests, paired or unpaired as
appropriate, or by one-way ANOVA and Tukey’s post test for more than two
groups. Non-parametric data (atherosclerosis) are presented as the median
and analyzed using the Mann-Whitney test. Differences were considered sta-
tistically significant if p % 0.05. Statistical analysis was carried out using
GraphPad Prism.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.02.043.AUTHOR CONTRIBUTIONS
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